📊 CVAT Key Takeaways
Investment Thesis
Cavitation Technologies exhibits terminal financial distress with revenue collapsing 85% YoY to $3K, negative stockholders' equity of -$248K, and chronic operating losses of -$723K. The company burns cash at an unsustainable rate (-$401K operating cash flow) while holding minimal liquid assets ($31K) against $303K in liabilities, indicating imminent solvency risk.
CVAT Strengths
- Maintains positive gross margin at 100% on minimal revenue base
- Retains $31K in cash reserves providing short-term liquidity buffer
- Agricultural services sector has long-term demand fundamentals
CVAT Risks
- Negative stockholders' equity of -$248K indicates technical insolvency
- Revenue near zero ($3K) with 85% YoY decline suggests business model failure
- Operating cash burn of -$401K annually unsustainable given $31K cash position
- Current ratio of 0.29x and quick ratio of 0.22x indicate critical liquidity crisis
- $150K long-term debt obligations exceed total assets of $55K
- Negative operating and net margins exceeding -24,000% reflect structural unprofitability
Key Metrics to Watch
- Cash position depletion rate and months of runway remaining
- Revenue stabilization or further deterioration trajectory
- Debt covenant compliance status and refinancing needs
- Operating cash flow trend and path to breakeven
CVAT Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CVAT Profitability Ratios
CVAT vs Default Sector
How Cavitation Technologies, Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CVAT Balance Sheet & Liquidity
CVAT 5-Year Financial Trend
5-Year Trend Summary: Cavitation Technologies, Inc.'s revenue has declined by 47% over the 5-year period, indicating business contraction. The most recent EPS of $0.00 indicates the company is currently unprofitable.
CVAT Growth Metrics (YoY)
CVAT Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | N/A | $352.0K | $0.00 |
| Q1 2026 | N/A | -$227.0K | $0.00 |
| Q3 2025 | $122.0K | $64.0K | $0.00 |
| Q2 2025 | $76.0K | -$16.0K | $0.00 |
| Q1 2025 | N/A | -$227.0K | $0.00 |
| Q3 2024 | $61.0K | $64.0K | $0.00 |
| Q2 2024 | $58.0K | -$16.0K | $0.00 |
| Q1 2024 | N/A | -$73.0K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CVAT Capital Allocation
CVAT SEC Filings
Access official SEC EDGAR filings for Cavitation Technologies, Inc. (CIK: 0001376793)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CVAT
What is the AI rating for CVAT?
Cavitation Technologies, Inc. (CVAT) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CVAT's key strengths?
Maintains positive gross margin at 100% on minimal revenue base. Retains $31K in cash reserves providing short-term liquidity buffer.
What are the risks of investing in CVAT?
Negative stockholders' equity of -$248K indicates technical insolvency. Revenue near zero ($3K) with 85% YoY decline suggests business model failure.
What is CVAT's revenue and growth?
Cavitation Technologies, Inc. reported revenue of $3.0K.
Does CVAT pay dividends?
Cavitation Technologies, Inc. does not currently pay dividends.
Where can I find CVAT SEC filings?
Official SEC filings for Cavitation Technologies, Inc. (CIK: 0001376793) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CVAT's EPS?
Cavitation Technologies, Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.